Open AccessNew onset of generalized myasthenia gravis developed after a new coronavirus infection (COVID-19)
Author(s) -
Т. М. Алексеева,
Patimat Isabekova,
М. П. Топузова,
Н В Скрипченко
Publication year - 2021
Publication title -
žurnal infektologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.185
H-Index - 5
eISSN - 2499-9865
pISSN - 2072-6732
DOI - 10.22625/2072-6732-2021-13-4-127-132
Subject(s) - myasthenia gravis , covid-19 , thymoma , pandemic , immunology , coronavirus , medicine , immune system , virology , disease , infectious disease (medical specialty) , outbreak
Development of various immune-mediated neurological complications after a viral infection is of particular interest to medical society during a pandemic of COVID-19. It was found that SARS-CoV-2 has the ability to cause hyperstimulation of the immune system, thereby initiating developing of autoimmune diseases. The article describes a clinical case of new onset of generalized myasthenia gravis with thymoma in a patient after previous COVID-19.